Clear Scientific News

Clear Scientific received continued support to further test novel atropine injectable

Cambridge, Massachusetts | August 2021 Clear Scientific recently received continued funding and support to further test and develop our...

Clear Scientific receives award to develop a stable, multidose vial formulation of scopolamine

Cambridge, Massachusetts | August 2021 Clear Scientific received an award to develop a stable, multidose vial (MDV) formulation of...

Clear Scientific Presents at 6th Annual Chemistry and Pharmacology of Drug Abuse Conference

Boston, Massachusetts | August 2021 Clear Scientific’s Chief Scientific Officer, Mitchell Zakin PhD, Executive VP Chemistry, Xinhua Li...

Clear Scientific continues development of life-saving Medical Counter Measures

Cambridge, Massachusetts | January 2021 Clear Scientific, Inc (CSInc) is excited to announce continued support from government agencies...

Clear Scientific Inc. receives $12MM grant from the National Institute on Drug Abuse (NIDA)

Cambridge, Massachusetts | October 2020 Clear Scientific Inc. receives $12MM grant from the National Institute on Drug Abuse (NIDA) to...

Clear Scientific receives NIDA grant to develop opioid intoxication countermeasure

Cambridge, Massachusetts | October 2020 Clear Scientific Inc. receives grant from NIDA to develop an antidote against acute intoxication...

Clear Scientific Welcomes New Board Member

Cambridge, Massachusetts | April 2020 Clear Scientific is excited to welcome our new Board of Directors member Emme Deland. Ms. Deland is...

Clear Scientific Celebrates its First Anniversary

Cambridge, Massachusetts | March 2020 Clear Scientific has surpassed a major milestone on its journey to success. On March 1, 2020 we...

Clear Scientific's Xinhua Li Presents at Medical Countermeasure Meeting

Rockville, Maryland | August 2019 The Executive Vice President of Chemistry for Clear Scientific, Xinhua Li, Ph.D., presented at the...